Printer Friendly

Articles from Clinical Chemistry (February 1, 2011)

1-33 out of 33 article(s)
Title Author Type Words
Action to control cardiovascular risk in diabetes (ACCORD) trial--clinical implications. Ismail-Beigi, Faramarz 2168
Agreement between fasting and postprandial LDL cholesterol measured with 3 methods in patients with type 2 diabetes mellitus. Lund, Soren S.; Petersen, Martin; Frandsen, Merete; Smidt, Ulla M.; Parving, Hans-Henrik; Vaag, Alla 7081
All Is Well That Ends Well. Anand, Usha Poem 655
Autoimmune markers in diabetes. Winter, William E.; Schatz, Desmond A. 6773
Biomarkers in fasting serum to estimate glucose tolerance, insulin sensitivity, and insulin secretion. Goldfine, Allison B.; Gerwien, Robert W.; Kolberg, Janice A.; OShea, Sheila; Hamren, Sarah; Hein, Gl 7106
Common variations in the genes encoding C-reactive protein, tumor necrosis factor-[alpha], and interleukin-6, and the risk of clinical diabetes in the women's health initiative observational study. Chan, Kei-hang K.; Brennan, Kathleen; You, Nai-chieh Y.; Lu, Xuyang; Song, Yiqing; Hsu, Yi-Hsiang; C 7322
Computational methods are significant determinants of the associations and definitions of insulin resistance using the homeostasis model assessment in women of reproductive age. Safar, Fatma H.; Mojiminiyi, Olusegun A.; Al-Rumaih, Hazem M.; Diejomaoh, Michael F. 5235
Determining stability of stored samples retrospectively: the validation of glycated albumin. Nathan, David M.; Steffes, Michael W.; Sun, Wanjie; Rynders, Gregory P.; Lachin, John M. 3588
Diabetes: advances and controversies. Sacks, David B.; Fonseca, Vivian; Goldfine, Allison B. 1353
Drug-induced changes in risk/biomarkers and their relationship with renal and cardiovascular long-term outcome in patients with diabetes. Miao, Yan; Smink, Paul A.; de Zeeuw, Dick; Heerspink, Hiddo J. Lambers 8031
Framingham study insights on diabetes and cardiovascular disease. Kannel, William B. 1088
Gaps in the glycation gap hypothesis. Sacks, David B.; Nathan, David M.; Lachin, John M. 2629
Genetics of type 1 diabetes. Steck, Andrea K.; Rewers, Marian J. 6874
Genetics of type 2 diabetes. Ahlqvist, Emma; Ahluwalia, Tarunveer Singh; Groop, Leif 11835
Hemoglobin [A.sub.1c] to diagnose diabetes: why the controversy over adding a new tool? Kirkman, M. Sue; Kendall, David M. 2043
Hypoglycemia and vascular disease. Younk, Lisa M.; Davis, Stephen N. 1821
Interview: C. Ronald Kahn. Landau, Misia Interview 5888
Is diabetes mellitus a continuous spectrum? Brooks-Worrell, Barbara; Palmer, Jerry P. 3363
Labile hemoglobin [A.sub.1c]: unexpected indicator of preanalytical contraindications. Corbe-Guillard, Emmanuelle; Jaisson, Stephane; Pileire, Cecile; Gillery, Philippe Letter to the editor 1373
Louis Pasteur in his laboratory: entry of chemistry into medicine. Dominiczak, Marek H. 965
Personalized medicine in diabetes. Malandrino, Noemi; Smith, Robert J. 7785
Potential for electronic health records and online social networking to redefine medical research. Pearson, John F.; Brownstein, Catherine A.; Brownstein, John S. 7614
Prediabetes as a therapeutic target. Pour, Omid Rad; Dagogo-Jack, Samuel 4570
Pregnancy and diabetes management: advances and controversies. Castorino, Kristin; Jovanovic, Lois 8247
Progression of nephropathy in type 2 diabetes: the glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb [A.sub.1c]). Rodriguez-Segade, Santiago; Rodriguez, Javier; Cabezas-Agricola, Jose M.; Casanueva, Felipe F.; Cami 5481
Red cell transfusion decreases hemoglobin [A.sub.1c] in patients with diabetes. Spencer, David H.; Grossman, Brenda J.; Scott, Mitchell G. Letter to the editor 1322
Serum soluble CD163 predicts risk of type 2 diabetes in the general population. Moller, Holger J.; Frikke-Schmidt, Ruth; Moestrup, Soren K.; Nordestgaard, Borge G.; Tybjaerg-Hansen 5351
Status of hemoglobin [A.sub.1c] measurement and goals for improvement: from chaos to order for improving diabetes care. Little, Randie R.; Rohlfing, Curt L.; Sacks, David B. 6776
The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients. Vila, Greisa; Riedl, Michaela; Anderwald, Christian; Resl, Michael; Handisurya, Ammon; Clodi, Martin 4363
Therapeutic approaches to target inflammation in type 2 diabetes. Goldfine, Allison B.; Fonseca, Vivian; Shoelson, Steven E. 4754
Unexpected hemoglobin [A.sub.1c] results. Sofronescu, Alina-Gabriela; Williams, Laurie M.; Andrews, Dorinda M.; Zhu, Yusheng 3745
Urinary catalytic iron in obesity. Thethi, Tina K.; Parsha, Kaushik; Rajapurkar, Mohan; Mukhopadhyay, Banibrata; Shah, Sudhir; Yau, C. 5229
Urinary catalytic iron in patients with type 2 diabetes without microalbuminuria--a substudy of the ACCORD trial. Thethi, Tina; Rajapurkar, Mohan; Walker, Patrick; McDuffie, Roberta; Goff, David C., Jr.; Probstfiel Letter to the editor 1791

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters